The 3-day Canadian Consensus Development Conference on Surveillance & Screening for AROs (Antimicrobial-Resistant Organisms), will be held in Calgary, Alberta from June 18–20, 2014. It is the first event of its kind in Canada to look at issues in the field of AROs.
This conference will be of interest to clinicians, policy-makers, managers, researchers, and students with an interest in AROs. It will address issues in public health, infectious diseases, laboratory medicine, and related fields.
The Consensus Conference model is an exciting format, geared to creating maximum impact on real-world clinical policy and practice. Leading experts from Canada, the US, UK and EU will address a wide range of issues, including:
- Overview – What are AROs? What burden do they impose on patients and the health system? Why does control of AROs vary so much?
- Surveillance – Why should we conduct surveillance? What outcomes do we want, and are we achieving them?
- Screening – What is appropriate screening for AROs in various settings? Should we screen for AROs – Pro versus Con.
- What factors can facilitate or hinder effective ARO control in practice? Organizational and cultural factors; Lab capacity.
- Ethical and policy implications – What are the impacts of screening on patients and others? Can screening do harm? What is the economic cost/benefit of screening? What can patients, the public, and health care professionals do to help?
- Research/Evidence – What are the most important gaps in our knowledge? How should we evaluate ARO screening in the future? What are the barriers to effective research and what strategies can address them?
On the final day of the conference, an expert Jury chaired by Dr. Tom Marrie, Dean of Medicine at Dalhousie, will release a Consensus Statement summarizing the evidence and making recommendations for policy and practice in Canada and other countries.
IHE’s Consensus Development Conferences are adapted from the model created by the US National Institutes of Health (NIH) to increase the dissemination and impact of findings from research. Our conferences build on the success of the NIH model in the Canadian context, with a flexible organizational structure and a focus on broad policy issues, as well as clinical and scientific questions.
For more information on the conference, visit www.AROsCalgary2014.ca